D.A. Davidson & CO. Buys 5,447 Shares of Oracle Corporation (NYSE:ORCL)

D.A. Davidson & CO. grew its position in Oracle Corporation (NYSE:ORCL - Free Report) by 5.6% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 103,357 shares of the enterprise software provider's stock after purchasing an additional 5,447 shares during the period. D.A. Davidson & CO.'s holdings in Oracle were worth $14,450,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Norges Bank acquired a new position in shares of Oracle in the 4th quarter valued at approximately $2,216,314,000. Raymond James Financial Inc. bought a new stake in shares of Oracle in the fourth quarter valued at about $930,095,000. GAMMA Investing LLC boosted its position in shares of Oracle by 15,012.3% during the first quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock worth $664,810,000 after buying an additional 4,723,631 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Oracle by 20.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock worth $2,303,858,000 after buying an additional 2,350,448 shares in the last quarter. Finally, Vanguard Group Inc. raised its position in Oracle by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider's stock valued at $26,231,127,000 after buying an additional 2,296,069 shares during the last quarter. 42.44% of the stock is owned by institutional investors.

Insider Activity

In other Oracle news, Vice Chairman Jeffrey Henley sold 400,000 shares of the stock in a transaction dated Thursday, June 12th. The stock was sold at an average price of $190.42, for a total transaction of $76,168,000.00. Following the completion of the sale, the insider directly owned 1,097,576 shares in the company, valued at approximately $209,000,421.92. This trade represents a 26.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Naomi O. Seligman sold 2,866 shares of Oracle stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $149.53, for a total value of $428,552.98. Following the completion of the transaction, the director directly owned 31,764 shares of the company's stock, valued at approximately $4,749,670.92. This trade represents a 8.28% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 440,366 shares of company stock worth $83,103,603 over the last quarter. Company insiders own 42.20% of the company's stock.

Analysts Set New Price Targets

ORCL has been the subject of several analyst reports. Piper Sandler restated a "neutral" rating and issued a $130.00 price objective on shares of Oracle in a report on Wednesday, June 11th. UBS Group set a $250.00 price target on Oracle and gave the company a "buy" rating in a research note on Wednesday, June 25th. Stifel Nicolaus raised Oracle from a "hold" rating to a "buy" rating and boosted their price target for the stock from $180.00 to $250.00 in a research report on Monday. TD Cowen upped their price objective on Oracle from $250.00 to $275.00 and gave the company a "buy" rating in a research note on Thursday. Finally, Jefferies Financial Group increased their price objective on shares of Oracle from $190.00 to $200.00 and gave the company a "buy" rating in a research report on Monday, June 9th. Ten analysts have rated the stock with a hold rating, twenty-two have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, Oracle has an average rating of "Moderate Buy" and an average price target of $204.15.

Oracle Price Performance

Shares of NYSE ORCL traded up $7.41 during midday trading on Friday, reaching $237.39. 18,441,376 shares of the company were exchanged, compared to its average volume of 10,140,491. Oracle Corporation has a one year low of $118.86 and a one year high of $237.99. The stock's 50-day moving average price is $176.16 and its 200-day moving average price is $163.79. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 4.07. The stock has a market cap of $666.79 billion, a P/E ratio of 54.70, a PEG ratio of 3.44 and a beta of 1.39.

Oracle (NYSE:ORCL - Get Free Report) last released its quarterly earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.06. Oracle had a return on equity of 87.34% and a net margin of 21.68%. The company had revenue of $15.90 billion for the quarter, compared to analysts' expectations of $15.58 billion. During the same period in the previous year, the business posted $1.63 earnings per share. The business's quarterly revenue was up 11.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 24th. Shareholders of record on Thursday, July 10th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, July 10th. This represents a $2.00 annualized dividend and a yield of 0.84%. Oracle's payout ratio is 46.08%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.